Product Code: ETC8838875 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Crohns Disease market in the Philippines is gradually expanding as awareness of gastrointestinal disorders increases. Diagnosis and treatment remain concentrated in urban healthcare facilities. The market includes biologics, anti-inflammatory drugs, and surgical interventions. However, high treatment costs and limited access to gastroenterologists are barriers to broader patient care.
The Crohns disease market in the Philippines is growing slowly with increasing recognition of inflammatory bowel disease. Diagnostic improvements, specialist clinics, and availability of biologic therapies are supporting both patient access and market expansion.
This market is constrained by underdiagnosis due to low awareness and limited access to gastrointestinal specialists. Many patients experience delayed or misdiagnosed conditions, which reduces treatment efficacy. The high cost of biologic treatments, limited insurance coverage, and inadequate chronic disease management infrastructure further restrict market growth and patient outcomes.
As awareness and diagnosis of Crohn`s disease increase, investment opportunities are emerging in biologics distribution, gastroenterology clinic chains, and advanced diagnostics. Investors can also support educational campaigns to improve disease awareness, enhancing market penetration for global pharmaceutical brands and improving access to advanced treatment options.
The Department of Health recognizes Crohns disease under non-communicable diseases, and government policy promotes access to gastroenterology services in tertiary hospitals. PhilHealth partially covers some treatments, while public hospitals are guided to enhance diagnosis and therapy availability under the UHC framework.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Crohn's Disease Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Crohn's Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Crohn's Disease Market - Industry Life Cycle |
3.4 Philippines Crohn's Disease Market - Porter's Five Forces |
3.5 Philippines Crohn's Disease Market Revenues & Volume Share, By Procedures, 2021 & 2031F |
3.6 Philippines Crohn's Disease Market Revenues & Volume Share, By Therapeutic type, 2021 & 2031F |
3.7 Philippines Crohn's Disease Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Philippines Crohn's Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Philippines Crohn's Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of Crohn's disease in the Philippines |
4.2.2 Growing healthcare infrastructure and access to advanced treatments |
4.2.3 Rising prevalence of risk factors such as smoking and unhealthy diet |
4.3 Market Restraints |
4.3.1 Limited healthcare budget and affordability issues for expensive Crohn's disease treatments |
4.3.2 Lack of specialized healthcare professionals and facilities for managing Crohn's disease in the Philippines |
4.3.3 Regulatory challenges and delays in the approval of new treatments |
5 Philippines Crohn's Disease Market Trends |
6 Philippines Crohn's Disease Market, By Types |
6.1 Philippines Crohn's Disease Market, By Procedures |
6.1.1 Overview and Analysis |
6.1.2 Philippines Crohn's Disease Market Revenues & Volume, By Procedures, 2021- 2031F |
6.1.3 Philippines Crohn's Disease Market Revenues & Volume, By Colonoscopy, 2021- 2031F |
6.1.4 Philippines Crohn's Disease Market Revenues & Volume, By Flexible Sigmoidoscopy, 2021- 2031F |
6.1.5 Philippines Crohn's Disease Market Revenues & Volume, By Computerized Tomography (CT), 2021- 2031F |
6.1.6 Philippines Crohn's Disease Market Revenues & Volume, By Magnetic Resonance Imaging (MRI), 2021- 2031F |
6.1.7 Philippines Crohn's Disease Market Revenues & Volume, By Capsule Endoscopy, 2021- 2031F |
6.1.8 Philippines Crohn's Disease Market Revenues & Volume, By Double-Balloon Endoscopy, 2021- 2031F |
6.2 Philippines Crohn's Disease Market, By Therapeutic type |
6.2.1 Overview and Analysis |
6.2.2 Philippines Crohn's Disease Market Revenues & Volume, By Non-surgical, 2021- 2031F |
6.2.3 Philippines Crohn's Disease Market Revenues & Volume, By Surgical, 2021- 2031F |
6.3 Philippines Crohn's Disease Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Philippines Crohn's Disease Market Revenues & Volume, By Hospitals and Clinics, 2021- 2031F |
6.3.3 Philippines Crohn's Disease Market Revenues & Volume, By Research Institutes, 2021- 2031F |
6.3.4 Philippines Crohn's Disease Market Revenues & Volume, By Diagnostic Centres, 2021- 2031F |
6.3.5 Philippines Crohn's Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Philippines Crohn's Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Philippines Crohn's Disease Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Philippines Crohn's Disease Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.4 Philippines Crohn's Disease Market Revenues & Volume, By Online, 2021- 2031F |
6.4.5 Philippines Crohn's Disease Market Revenues & Volume, By Others, 2021- 2031F |
7 Philippines Crohn's Disease Market Import-Export Trade Statistics |
7.1 Philippines Crohn's Disease Market Export to Major Countries |
7.2 Philippines Crohn's Disease Market Imports from Major Countries |
8 Philippines Crohn's Disease Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis for Crohn's disease patients in the Philippines |
8.2 Number of healthcare facilities offering specialized care for Crohn's disease |
8.3 Patient adherence to treatment plans and follow-up appointments |
8.4 Patient-reported outcomes related to quality of life improvements |
8.5 Rate of adoption of new treatment guidelines for Crohn's disease in the Philippines |
9 Philippines Crohn's Disease Market - Opportunity Assessment |
9.1 Philippines Crohn's Disease Market Opportunity Assessment, By Procedures, 2021 & 2031F |
9.2 Philippines Crohn's Disease Market Opportunity Assessment, By Therapeutic type, 2021 & 2031F |
9.3 Philippines Crohn's Disease Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Philippines Crohn's Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Philippines Crohn's Disease Market - Competitive Landscape |
10.1 Philippines Crohn's Disease Market Revenue Share, By Companies, 2024 |
10.2 Philippines Crohn's Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |